Searched over 200M research papers
10 papers analyzed
Some studies suggest angina itself is not inherently dangerous, while other studies indicate it can be associated with significant risks such as cardiac arrest, sudden death, and severe infections if not properly managed.
20 papers analyzed
Angina pectoris is a type of chest pain or discomfort caused by reduced blood flow to the heart muscle, often a symptom of ischemic heart disease (IHD). It is a common clinical manifestation with a prevalence of 3-4% among UK adults, leading to significant healthcare resource utilization. Angina typically occurs after physical exertion or emotional stress due to a mismatch between myocardial oxygen supply and demand.
While angina itself is not always immediately fatal, it can be a marker for more severe cardiovascular events. For instance, variant angina can lead to serious complications such as cardiac arrest and sudden unexpected death, even in the absence of severe coronary stenosis. The risk of these fatal events is significantly increased in patients with a history of angina-linked syncope or serious arrhythmias. Adequate vasodilator therapy, including calcium channel blockers, can help mitigate these risks.
Angina is not just a symptom but also a predictor of major adverse cardiac events (MACE) such as myocardial infarction and sudden death . The presence of angina indicates underlying coronary artery disease (CAD), which continues to predict major coronary events even after the initial development of angina. This makes angina a significant morbidity that impedes quality of life and necessitates effective treatment strategies.
Angina in women is associated with more adverse outcomes compared to men, despite women having less obstructive coronary artery disease and better left ventricular function. Women with angina often experience more severe morbidity and mortality, which may be due to microvascular disease rather than significant obstructive coronary artery disease. This highlights the need for gender-specific diagnostic and therapeutic strategies.
Effective management of angina involves both pharmacologic and non-pharmacologic approaches. Common medications include beta-blockers, nitrates, calcium channel blockers, and ranolazine. In some cases, revascularization procedures are indicated, although a substantial percentage of patients may still experience recurrent angina post-procedure. For refractory angina, advanced treatments such as enhanced external counterpulsation, transmyocardial revascularization, and stem cell therapy are considered.
Mental stress can exacerbate angina symptoms and is associated with increased neural responses in specific brain regions, indicating an upregulated pain perception response. This suggests that psychological factors play a significant role in the experience and management of angina, particularly in patients with stable CAD.
In summary, while angina itself may not always be immediately dangerous, it is a significant indicator of underlying cardiovascular issues that can lead to severe outcomes such as cardiac arrest, myocardial infarction, and sudden death. Effective management, including both medical and psychological interventions, is crucial to improving patient outcomes and quality of life. Gender-specific considerations and advanced treatment options are also essential in addressing the complexities of angina.
Most relevant research papers on this topic